Advertisement

ATR

AptarGroup, Inc.

Healthcare · USD

Set alert

Price alert · ATR

All alert types
137.20 USD +6.56 +5.02%
As of Oct 30, 2026 Extended hours 137.20 0.00%
Bid
136.90 × 100
Ask
137.40 × 200
135.52 Day range 142.31
111.94 52-week range 145.72
YTD
+12.50%
1 year
+10.32%
Open
138.59
Prev close
130.64
Mkt cap
8.72B
Vol
1.01M
Avg vol
454.75K
EPS
5.54
P/E
24.77
Div yield
1.47%
More statistics
Low
135.52
High
142.31
Forward P/E
22.20
Beta
0.34
Short ratio
4.15
Inst. own
97.90%
Dividend
1.92
Ex-div date
Jul 29, 2026
Earnings
Feb 4, 2027
50-d avg
125.78
200-d avg
126.89
1y target
162.25

5D chart

Chart tools
Interval
ATR five-day price chart125.0129.3133.7138.0142.3Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
8.72B
Enterprise value
9.57B
Trailing P/E
24.76
Forward P/E
22.20
PEG ratio
2.91
Price / sales
2.22
Price / book
3.32
EPS (TTM)
5.54
Beta
0.34
Dividend yield
1.47%
Payout ratio
34.12%
Profit margin
9.22%
Revenue (TTM)
3.93B
Revenue growth
6.30%
Free cash flow
265.98M
Total cash
197.27M
Total debt
1.41B
Return on equity
13.46%
Shares outstanding
63.58M
Short % of float
3.70%
50-day average
125.78
200-day average
126.89

Analyst view

Consensus: buy

Buy
Price target (mean) 162.25 +18.3% upside
Target (low)
135.00
Target (mean)
162.25
Target (high)
220.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Feb 4, 2027

Expected Feb 4, 2027. Consensus EPS estimate 1.41.

Earnings history

Financials — quick view

All financials
ATR Revenue — quarterly 1.03B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ATR Net income — quarterly 87.57M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ATR EPS — quarterly 1.38
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ATR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20261.38———
Oct 29, 2026Sep 30, 20261.471.52+0.05+3.40%
Jul 30, 2026Jun 30, 20261.351.42+0.07+5.19%
Apr 30, 2026Mar 31, 20261.151.19+0.04+3.48%
Feb 5, 2026Dec 31, 20251.241.25+0.01+0.81%
Oct 30, 2025Sep 30, 20251.571.62+0.05+3.18%

Upgrades / downgrades

ATR analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026UBSinit—Neutral
Aug 3, 2026Wells FargomainOverweightOverweight
May 4, 2026Wells FargomainOverweightOverweight
Mar 20, 2026Wells FargoupEqual-WeightOverweight
Jan 6, 2026Wells FargodownOverweightEqual-Weight
Nov 3, 2025Wells FargomainOverweightOverweight

About AptarGroup, Inc.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
aptar.com

News

Your note

Sign in to keep a note on ATR — it syncs with the Stock Master app.

Insider holders

ATR insider holders
InsiderRelationLatest transactionDateShares held
ACKERMAN DANIELOfficerStock Award(Grant)Apr 30, 202632,779
GONG XIANGWEIOfficerSaleMay 25, 202611,416
KANU VANESSAChief Financial OfficerStock Award(Grant)Mar 18, 202613,686
OWENS B CRAIGDirectorStock Award(Grant)Jul 15, 202611,233
PRIEUR MARCOfficerSaleAug 3, 202615,823
TANDA STEPHAN BChief Executive OfficerConversion of Exercise of derivative securityAug 2, 2026241,879

Institution ownership

ATR institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.65%6,137,894841.84MJun 29, 2026
State Farm Mutual Automobile Insurance Co7.46%4,744,564650.74MJun 29, 2026
Vanguard Portfolio Management LLC5.72%3,638,724499.07MJun 29, 2026
Morgan Stanley5.54%3,523,908483.32MJun 29, 2026
Vanguard Capital Management LLC4.55%2,893,751396.89MJun 29, 2026
State Street Corporation4.50%2,863,390392.73MJun 29, 2026

Fund ownership

ATR fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%2,264,781310.63MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19%2,026,121277.89MJun 29, 2026
Victory Portfolios-Victory Sycamore Established Value Fund2.92%1,858,000254.83MJun 29, 2026
Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund2.73%1,732,643237.64MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.30%1,464,114200.81MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund1.46%927,166127.17MJun 29, 2026
Advertisement